Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 2 Pulmonary Hypertension”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableEnrolling By InvitationNCT06052072
What this trial is testing

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Who this might be right for
Group 2 Pulmonary HypertensionHeart Failure
Gradient Denervation Technologies 50
Testing effectiveness (Phase 2)Study completedNCT02664558
What this trial is testing

Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 61
Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Not applicableStudy completedNCT05001711
What this trial is testing

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Aria CV, Inc 18
Testing effectiveness (Phase 2)Ended earlyNCT03884465
What this trial is testing

Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Liquidia Technologies, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Not applicableUnknownNCT05856461
What this trial is testing

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Who this might be right for
Atrial FibrillationPulmonary Hypertension
Meshalkin Research Institute of Pathology of Circulation 116
Testing effectiveness (Phase 2)WithdrawnNCT04882774
What this trial is testing

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Mardi Gomberg -Maitland MD, MSc
Testing effectiveness (Phase 2)Ended earlyNCT02736149
What this trial is testing

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT05737940
What this trial is testing

AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Who this might be right for
Pulmonary Hypertension (World Health Organization Group 2)Heart Failure
AstraZeneca 260
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Large-scale testing (Phase 3)Study completedNCT01720524
What this trial is testing

Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Who this might be right for
Pulmonary Hypertension, Familial Persistent, of the Newborn
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 59
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Post-approval studies (Phase 4)Looking for participantsNCT07147114
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Who this might be right for
Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEF+2 more
Gachon University Gil Medical Center 64
Large-scale testing (Phase 3)Active Not RecruitingNCT04175600
What this trial is testing

Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Actelion 138
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Next Page